GB0411770D0 - Immuno inhibitory heterocyclic compouds - Google Patents
Immuno inhibitory heterocyclic compoudsInfo
- Publication number
- GB0411770D0 GB0411770D0 GBGB0411770.1A GB0411770A GB0411770D0 GB 0411770 D0 GB0411770 D0 GB 0411770D0 GB 0411770 A GB0411770 A GB 0411770A GB 0411770 D0 GB0411770 D0 GB 0411770D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- nr7c
- nhc
- optionally substituted
- heterocyclic compouds
- immuno
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 125000000623 heterocyclic group Chemical group 0.000 title 1
- 230000003259 immunoinhibitory effect Effects 0.000 title 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 abstract 1
- 108091008648 NR7C Proteins 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 208000006673 asthma Diseases 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000002843 carboxylic acid group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- -1 trifuoromethyl Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0411770.1A GB0411770D0 (en) | 2004-05-26 | 2004-05-26 | Immuno inhibitory heterocyclic compouds |
| AT05738153T ATE501146T1 (de) | 2004-05-26 | 2005-04-26 | Immunoinhibitorische heterocyclische verbindungen |
| DE602005026805T DE602005026805D1 (de) | 2004-05-26 | 2005-04-26 | Immunoinhibitorische heterocyclische verbindungen |
| PCT/GB2005/001583 WO2005116033A1 (en) | 2004-05-26 | 2005-04-26 | Immuno inhibitory heterocyclic compounds |
| US11/597,319 US7566713B2 (en) | 2004-05-26 | 2005-04-26 | Immuno inhibitory heterocyclic compounds |
| JP2007514067A JP4852537B2 (ja) | 2004-05-26 | 2005-04-26 | 免疫抑制へテロ環化合物 |
| EP05738153A EP1753765B1 (en) | 2004-05-26 | 2005-04-26 | Immuno inhibitory heterocyclic compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0411770.1A GB0411770D0 (en) | 2004-05-26 | 2004-05-26 | Immuno inhibitory heterocyclic compouds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0411770D0 true GB0411770D0 (en) | 2004-06-30 |
Family
ID=32671106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0411770.1A Ceased GB0411770D0 (en) | 2004-05-26 | 2004-05-26 | Immuno inhibitory heterocyclic compouds |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7566713B2 (https=) |
| EP (1) | EP1753765B1 (https=) |
| JP (1) | JP4852537B2 (https=) |
| AT (1) | ATE501146T1 (https=) |
| DE (1) | DE602005026805D1 (https=) |
| GB (1) | GB0411770D0 (https=) |
| WO (1) | WO2005116033A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2284172A1 (en) | 2003-03-14 | 2011-02-16 | MediGene Ltd. | Immunomodulating heterocyclic compounds |
| ES2315695T3 (es) | 2004-08-09 | 2009-04-01 | Medigene Ltd. | Oxopirazolocinolinas inmunomoduladoras como inhibidores de moleculas cd80. |
| GB0603522D0 (en) * | 2006-02-22 | 2006-04-05 | Avidex Ltd | Kinase inhibition |
| EP2883883A1 (en) | 2013-12-16 | 2015-06-17 | Cardio3 Biosciences S.A. | Therapeutic targets and agents useful in treating ischemia reperfusion injury |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ID16283A (id) * | 1996-03-20 | 1997-09-18 | Astra Pharma Prod | Senyawa yang berguna dibidang farmasi |
| GB9713707D0 (en) * | 1997-06-27 | 1997-09-03 | Merck Sharp & Dohme | Therapeutic agents |
| SE0102404D0 (sv) * | 2001-07-04 | 2001-07-04 | Active Biotech Ab | Novel immunomodulating compounds |
| EP2284172A1 (en) * | 2003-03-14 | 2011-02-16 | MediGene Ltd. | Immunomodulating heterocyclic compounds |
-
2004
- 2004-05-26 GB GBGB0411770.1A patent/GB0411770D0/en not_active Ceased
-
2005
- 2005-04-26 US US11/597,319 patent/US7566713B2/en not_active Expired - Lifetime
- 2005-04-26 DE DE602005026805T patent/DE602005026805D1/de not_active Expired - Lifetime
- 2005-04-26 WO PCT/GB2005/001583 patent/WO2005116033A1/en not_active Ceased
- 2005-04-26 JP JP2007514067A patent/JP4852537B2/ja not_active Expired - Fee Related
- 2005-04-26 EP EP05738153A patent/EP1753765B1/en not_active Expired - Lifetime
- 2005-04-26 AT AT05738153T patent/ATE501146T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1753765B1 (en) | 2011-03-09 |
| JP4852537B2 (ja) | 2012-01-11 |
| EP1753765A1 (en) | 2007-02-21 |
| JP2008500314A (ja) | 2008-01-10 |
| DE602005026805D1 (de) | 2011-04-21 |
| WO2005116033A1 (en) | 2005-12-08 |
| ATE501146T1 (de) | 2011-03-15 |
| US7566713B2 (en) | 2009-07-28 |
| US20080021033A1 (en) | 2008-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2005105732A8 (en) | Substituted methyl aryl or heteroaryl amide compounds | |
| NO20074071L (no) | Hydrazinometyl, hydrozonometyl og 5-leddete heterocykliske forbindelser som virker som MTOR inhibitorer og anvendelse derav som anti-cancer midler | |
| ATE523492T1 (de) | Chinolin- und chinoxalinderivate als inhibitoren der enzymatischen kinaseaktivität | |
| ATE537169T1 (de) | Piperidin- und piperazinderivate als p2x3- antagonisten | |
| WO2008146871A1 (ja) | グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規１，２，３，４－テトラヒドロキノキサリン誘導体 | |
| TW200604175A (en) | Ortho substituted aryl or heteroaryl amide compounds | |
| HRP20120460T1 (hr) | Novi 5-supstituirani hidantoini | |
| WO2007001975A8 (en) | Piperidine derivatives useful as histamine h3 antagonists | |
| WO2008157234A3 (en) | Mono and bis-ester derivatives of pyridinium and quinolinium compounds as environmentally friendly corrosion inhibitors | |
| WO2010003809A3 (en) | Liquid oxyalkylene bridged bis- and tris-phosphite ester mixtures | |
| ES2543607T3 (es) | Ciertas amidas sustituidas, método de obtención, y método de su uso | |
| EP1968131A4 (en) | MATERIAL FOR AN ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE | |
| DE602007002176D1 (de) | Mikropartikel, umfassend ein vernetztes polymer | |
| TW200800947A (en) | Trisubstituted amine compound | |
| ATE531718T1 (de) | Als hsp90-inhibitoren verwendete pyrrolopyrimidinderivate | |
| MX2009008509A (es) | Compuesto de anillo puenteado-aza. | |
| WO2007149448A3 (en) | Pyrazinones as cellular proliferation inhibitors | |
| EP1642880A4 (en) | PROTEIN INHIBITORS OF THE HSP90 FAMILY | |
| GB0510584D0 (en) | Organic compounds | |
| MX2008013728A (es) | Inductor de neurogenesis o agente terapeutico de neuropatia que abarca el derivado del eter alkilico o sal del mismo. | |
| ATE396182T1 (de) | Hemmstoffe des ep4-rezeptors | |
| MX2009013822A (es) | Derivado de morfolina. | |
| DE602006010864D1 (de) | Kohlenstoffgebundene substituierte piperidine und derivate daraus als histamin-h3-antagonisten | |
| MXPA05009667A (es) | Compuestos heterociclicos inmunomoduladores. | |
| GB0411770D0 (en) | Immuno inhibitory heterocyclic compouds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |